
Nizal S. Chandrakumar
Examiner (ID: 111, Phone: (571)272-6202 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1625 |
| Total Applications | 2819 |
| Issued Applications | 1922 |
| Pending Applications | 209 |
| Abandoned Applications | 730 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10749717
[patent_doc_number] => 20160095868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-07
[patent_title] => 'COMPOSITION, FORMULATIONS AND METHODS OF MAKING AND USING BOTANICALS AND NATURAL COMPOUNDS FOR THE PROMOTION OF HEALTHY BRAIN AGING'
[patent_app_type] => utility
[patent_app_number] => 14/785565
[patent_app_country] => US
[patent_app_date] => 2014-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 40638
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14785565
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/785565 | COMPOSITION, FORMULATIONS AND METHODS OF MAKING AND USING BOTANICALS AND NATURAL COMPOUNDS FOR THE PROMOTION OF HEALTHY BRAIN AGING | Apr 16, 2014 | Abandoned |
Array
(
[id] => 9686773
[patent_doc_number] => 20140243538
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-28
[patent_title] => 'PRETREATED EPOXIDATION CATALYST AND A PROCESS FOR PRODUCING AN OLEFIN THEREWITH'
[patent_app_type] => utility
[patent_app_number] => 14/252149
[patent_app_country] => US
[patent_app_date] => 2014-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4827
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14252149
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/252149 | Pretreated epoxidation catalyst and a process for producing an olefin therewith | Apr 13, 2014 | Issued |
Array
(
[id] => 10699355
[patent_doc_number] => 20160045502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-18
[patent_title] => 'THERAPEUTIC BENEFIT OF SUBOPTIMALLY ADMINISTERED CHEMICAL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/783137
[patent_app_country] => US
[patent_app_date] => 2014-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 66070
[patent_no_of_claims] => 303
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14783137
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/783137 | Therapeutic benefit of suboptimally administered chemical compounds | Apr 7, 2014 | Issued |
Array
(
[id] => 11283683
[patent_doc_number] => 09499528
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-22
[patent_title] => 'Class of near infrared molecular probes for biological applications'
[patent_app_type] => utility
[patent_app_number] => 14/247812
[patent_app_country] => US
[patent_app_date] => 2014-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9653
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14247812
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/247812 | Class of near infrared molecular probes for biological applications | Apr 7, 2014 | Issued |
Array
(
[id] => 9858711
[patent_doc_number] => 20150038728
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-05
[patent_title] => 'NOVEL ARYLATED CAMPHENES, PROCESSES FOR THEIR PREPARATION AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/230267
[patent_app_country] => US
[patent_app_date] => 2014-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 19736
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14230267
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/230267 | Arylated camphenes, processes for their preparation and uses thereof | Mar 30, 2014 | Issued |
Array
(
[id] => 9635694
[patent_doc_number] => 20140213802
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-31
[patent_title] => '(-)-Epigallocatechin Gallate Derivatives for Inhibiting Proteasome'
[patent_app_type] => utility
[patent_app_number] => 14/229315
[patent_app_country] => US
[patent_app_date] => 2014-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 21084
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14229315
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/229315 | (−)-Epigallocatechin gallate derivatives for inhibiting proteasome | Mar 27, 2014 | Issued |
Array
(
[id] => 9772569
[patent_doc_number] => 20140296232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-02
[patent_title] => 'COMPOUNDS FOR THE TREATMENT OF MYCOBACTERIAL INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 14/227372
[patent_app_country] => US
[patent_app_date] => 2014-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11934
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14227372
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/227372 | Compounds for the treatment of mycobacterial infections | Mar 26, 2014 | Issued |
Array
(
[id] => 9799655
[patent_doc_number] => 20150011597
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-08
[patent_title] => 'DUAL-ACTING ANTIHYPERTENSIVE AGENTS'
[patent_app_type] => utility
[patent_app_number] => 14/227536
[patent_app_country] => US
[patent_app_date] => 2014-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48719
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14227536
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/227536 | DUAL-ACTING ANTIHYPERTENSIVE AGENTS | Mar 26, 2014 | Abandoned |
Array
(
[id] => 10920511
[patent_doc_number] => 20140323530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-30
[patent_title] => 'AMINE DERIVATIVE COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 14/226665
[patent_app_country] => US
[patent_app_date] => 2014-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 149122
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14226665
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/226665 | Amine derivative compounds for treating ophthalmic diseases and disorders | Mar 25, 2014 | Issued |
Array
(
[id] => 11858984
[patent_doc_number] => 09738655
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-22
[patent_title] => 'Tetrahydroisoquinolines containing substituted azoles as factor XIa inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/777763
[patent_app_country] => US
[patent_app_date] => 2014-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 107968
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14777763
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/777763 | Tetrahydroisoquinolines containing substituted azoles as factor XIa inhibitors | Mar 24, 2014 | Issued |
Array
(
[id] => 11827626
[patent_doc_number] => 09724354
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-08
[patent_title] => 'Combination of catalytic mTORC1/2 inhibitors and selective inhibitors of Aurora A kinase'
[patent_app_type] => utility
[patent_app_number] => 14/777888
[patent_app_country] => US
[patent_app_date] => 2014-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 70850
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14777888
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/777888 | Combination of catalytic mTORC1/2 inhibitors and selective inhibitors of Aurora A kinase | Mar 20, 2014 | Issued |
Array
(
[id] => 10554780
[patent_doc_number] => 09278977
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-03-08
[patent_title] => 'Process for manufacturing 5-chloromethyl-2,3-pyridine dicarboxylic acid anhydrides'
[patent_app_type] => utility
[patent_app_number] => 14/220561
[patent_app_country] => US
[patent_app_date] => 2014-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4392
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14220561
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/220561 | Process for manufacturing 5-chloromethyl-2,3-pyridine dicarboxylic acid anhydrides | Mar 19, 2014 | Issued |
Array
(
[id] => 10961583
[patent_doc_number] => 20140364613
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-11
[patent_title] => 'COMPOUNDS OF 3-(5-SUSTITUTED OXY-2, 4-DINITROPHENYL)-2-OXO-PROPIONIC ACID ESTER, SYNTHESIS AND APPLICATIONS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/218244
[patent_app_country] => US
[patent_app_date] => 2014-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8000
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14218244
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/218244 | Compounds of 3-(5-substituted Oxy-2, 4-dinitrophenyl)-2-oxo-propionic acid ester, synthesis and applications thereof | Mar 17, 2014 | Issued |
Array
(
[id] => 10677902
[patent_doc_number] => 20160024047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-28
[patent_title] => 'MULTISUBSTITUTED AROMATIC COMPOUNDS AS SERINE PROTEASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 14/776612
[patent_app_country] => US
[patent_app_date] => 2014-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43352
[patent_no_of_claims] => 92
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14776612
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/776612 | Multisubstituted aromatic compounds as serine protease inhibitors | Mar 16, 2014 | Issued |
Array
(
[id] => 10699358
[patent_doc_number] => 20160045506
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-18
[patent_title] => 'USE OF INHIBITORS OF BINDING BETWEEN A PAR-1 RECEPTOR AND ITS LIGANDS FOR THE TREATMENT OF GLIOMA'
[patent_app_type] => utility
[patent_app_number] => 14/776961
[patent_app_country] => US
[patent_app_date] => 2014-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 14025
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14776961
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/776961 | USE OF INHIBITORS OF BINDING BETWEEN A PAR-1 RECEPTOR AND ITS LIGANDS FOR THE TREATMENT OF GLIOMA | Mar 13, 2014 | Abandoned |
Array
(
[id] => 10675772
[patent_doc_number] => 20160021917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-28
[patent_title] => 'SWEETENER'
[patent_app_type] => utility
[patent_app_number] => 14/775336
[patent_app_country] => US
[patent_app_date] => 2014-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5237
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14775336
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/775336 | Sweetener | Mar 13, 2014 | Issued |
Array
(
[id] => 9882817
[patent_doc_number] => 08969581
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-03
[patent_title] => '5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the same'
[patent_app_type] => utility
[patent_app_number] => 14/211905
[patent_app_country] => US
[patent_app_date] => 2014-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 27572
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14211905
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/211905 | 5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the same | Mar 13, 2014 | Issued |
Array
(
[id] => 9965019
[patent_doc_number] => 09012635
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-21
[patent_title] => 'Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities'
[patent_app_type] => utility
[patent_app_number] => 14/214127
[patent_app_country] => US
[patent_app_date] => 2014-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17545
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14214127
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/214127 | Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities | Mar 13, 2014 | Issued |
Array
(
[id] => 11343434
[patent_doc_number] => 09527829
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-27
[patent_title] => 'Histone demethylase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/774338
[patent_app_country] => US
[patent_app_date] => 2014-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56832
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14774338
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/774338 | Histone demethylase inhibitors | Mar 12, 2014 | Issued |
Array
(
[id] => 9944471
[patent_doc_number] => 08993771
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-31
[patent_title] => 'Hepatitis B antiviral agents'
[patent_app_type] => utility
[patent_app_number] => 14/206496
[patent_app_country] => US
[patent_app_date] => 2014-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15829
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14206496
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/206496 | Hepatitis B antiviral agents | Mar 11, 2014 | Issued |